Financial Wire

Veon Unit Gets Antitrust Approval for TPL Insurance Stake Acquisition

-- Veon (VEON) said Tuesday the Competition Commission of Pakistan approved its Jazz International Holding unit's acquisition of a controlling stake in TPL Insurance for roughly 4.15 billion Pakistani Rupees ($14.6 million).

The target business holds a general insurer license and recorded a gross written premium of 5.7 billion Rupees alongside more than 277,000 issued policies as of Dec. 31, 2025.

The transaction is anticipated to close midyear, according to the company.

Price: $52.63, Change: $-0.12, Percent Change: -0.23%

Related Articles

Asia

Emerald Resources Progresses Western Australia, Cambodia Projects Over March Quarter

Emerald Resources (ASX:EMR) said it intersected gold mineralization at its Dingo Range Gold Project in Western Australia, as well as at its Memot Gold Project, Okvau Gold Mine, and exploration tenure in Cambodia during the quarter ended March 31, according to a Tuesday Australian bourse filing.The results were up to 45 meters at 4.1 grams per tonne gold from 619 meters at the Dingo Range Gold Project, including 18.5 meters at 5.2 grams per tonne gold from 641 meters.The company said that exploration since the January mineral resource estimate has targeted both open pit extensions and underground potential at the Dingo Range Gold Project.Drilling results from the Memot Gold Project were up to 2 meters at 50.3 grams per tonne gold from 40 meters and 14 meters at 3.4 grams per tonne gold from one meter, the filing added.Intersections from the Okvau Gold Mine were of up to 3 meters at 59 grams per tonne gold from 347 meters and 22 meters at 1.9 grams per tonne gold from 448 meters.

$ASX:EMR
Asia

Australian Clinical Labs Denies Claims Made in Class Action Filed in Victorian Supreme Court

Australian Clinical Labs (ASX:ACL) denied the claims made in the representative proceeding filed in the Victorian Supreme Court by a Michelle Raab-Ivanov and plans to "vigorously" defend it, according to a Tuesday filing with the Australian bourse.The proceeding was expressed to be on behalf of persons who were customers of the company and/or its Medlab Pathology subsidiary before July 15, 2022, and whose personal information was affected by a cyberattack on Medlab Pathology in February 2022, the filing said.The statement of claim purports to seek damages for affected individuals based on alleged breaches of the Australian Consumer Law, per the filing.

$ASX:ACL
Asia

Challenger to Redeem All Outstanding Challenger Capital Notes 3

Challenger (ASX:CGF) will redeem all of its outstanding Challenger capital notes 3 on May 25 at their face value of AU$100 each in cash, according to a Tuesday filing with the Australian bourse.The redemption has been approved by the Australian Prudential Regulation Authority.A final distribution of AU$1.47 per note is expected to be paid on May 25 to all registered holders as of May 15, the company said.

$ASX:CGF